Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial

K Baker1, G Chong, W D Foulkes

  • 1Department of Pathology, SMBD-Jewish General Hospital, Department of Oncology and Human Genetics, McGill University, Montreal, QC, Canada. kristi.baker@mcgill.ca

Histopathology
|September 19, 2006
PubMed
Abstract

Insights

Colorectal cancers with DNA mismatch repair deficiency retain lymphocytes due to transforming growth factor-beta (TGF-beta) pathway insensitivity. This TGF-beta refractoriness, linked to better prognosis, suggests targeting this pathway for cancer therapy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Colorectal cancers deficient in DNA mismatch repair (MMR) often exhibit numerous intraepithelial lymphocytes (IELs).
  • These CD8+ T cells express CD103, upregulated by transforming growth factor-beta (TGF-beta), and bind to E-cadherin on mucosal epithelia.
  • Many MMR-deficient cancers have mutations in the TGF-beta type II receptor, suggesting TGF-beta insensitivity.

Purpose of the Study:

  • To investigate if refractoriness to TGF-beta signaling contributes to IEL retention in colorectal cancers.
  • To identify predictors of increased lymphocytic infiltration independent of MMR status.

Main Methods:

  • Immunohistochemistry was used to analyze TGF-beta pathway components in MMR-deficient colorectal cancers.
  • Logistic regression analysis identified predictors of elevated lymphocytic infiltration.

Main Results:

  • Increased Smad4 expression was an independent predictor of marked lymphocyte infiltration.
  • Tumor cell proliferation and TGF-beta secretion also independently predicted higher lymphocyte infiltration.
  • These factors were identified independently of DNA mismatch repair status.

Conclusions:

  • Refractoriness to TGF-beta signaling in colorectal cancers plays a role in retaining lymphocytes within the tumor epithelium.
  • IEL infiltration is an independent predictor of a favorable prognosis.
  • The TGF-beta pathway represents a potential therapeutic target for colorectal cancer.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...